IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GALLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.954
EU - Europa 3.645
NA - Nord America 3.178
SA - Sud America 280
AF - Africa 52
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 10
Totale 11.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.993
CN - Cina 2.003
DE - Germania 1.415
IT - Italia 595
SG - Singapore 548
GB - Regno Unito 415
JP - Giappone 251
VN - Vietnam 224
HK - Hong Kong 213
FR - Francia 210
BR - Brasile 194
BD - Bangladesh 173
IN - India 169
SE - Svezia 156
ES - Italia 149
CA - Canada 142
TW - Taiwan 122
RU - Federazione Russa 114
NL - Olanda 112
IE - Irlanda 75
FI - Finlandia 64
KR - Corea 55
PL - Polonia 53
TR - Turchia 50
AU - Australia 46
DK - Danimarca 45
ID - Indonesia 32
CH - Svizzera 31
GR - Grecia 31
AR - Argentina 30
BE - Belgio 29
AT - Austria 25
UA - Ucraina 24
PT - Portogallo 23
RO - Romania 20
MX - Messico 18
IR - Iran 16
EC - Ecuador 15
CI - Costa d'Avorio 13
CO - Colombia 13
PH - Filippine 13
TH - Thailandia 13
PE - Perù 12
MA - Marocco 11
ZA - Sudafrica 11
IQ - Iraq 10
JO - Giordania 10
NO - Norvegia 10
AP - ???statistics.table.value.countryCode.AP??? 9
CZ - Repubblica Ceca 9
IL - Israele 7
RS - Serbia 7
SI - Slovenia 7
HU - Ungheria 6
MY - Malesia 6
BG - Bulgaria 5
LB - Libano 5
MO - Macao, regione amministrativa speciale della Cina 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
SA - Arabia Saudita 5
UY - Uruguay 5
VE - Venezuela 5
CL - Cile 4
DZ - Algeria 4
EG - Egitto 4
HN - Honduras 4
SY - Repubblica araba siriana 4
CR - Costa Rica 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LT - Lituania 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
ET - Etiopia 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
GD - Grenada 1
GL - Groenlandia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
Totale 11.164
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.227
Singapore 326
Ashburn 278
Redwood City 229
Chandler 223
Southend 213
Beijing 212
Shanghai 201
Fairfield 193
Milan 147
Hong Kong 132
San Jose 114
Guangzhou 109
Houston 97
Tokyo 94
Nanjing 89
Seattle 87
Wilmington 81
Taipei 74
New York 73
Dallas 70
Los Angeles 70
Woodbridge 70
Dublin 69
Council Bluffs 62
Shenyang 62
Zhengzhou 61
Hanoi 57
Ho Chi Minh City 57
Cambridge 55
Dearborn 54
Hangzhou 54
Helsinki 54
Hefei 53
Princeton 53
Toronto 53
Changsha 50
Wuhan 49
Chengdu 47
Ann Arbor 45
Santa Clara 43
London 42
Rome 38
Tianjin 35
Buffalo 33
Madrid 33
Berlin 31
Jinan 30
Phoenix 30
Lauterbourg 29
Chicago 28
Columbus 28
Bengaluru 27
Moscow 27
Seoul 27
São Paulo 27
Jakarta 26
Paris 26
Hebei 25
Munich 25
Nanchang 25
Central District 24
Des Moines 24
Fuzhou 21
Duncan 19
Istanbul 19
Naples 19
Boardman 18
Changchun 17
Hyderabad 17
Ottawa 17
Warsaw 17
Turin 16
Bologna 14
Da Nang 14
Abidjan 13
Amsterdam 13
Brussels 13
Chongqing 13
Kunming 13
Sydney 13
The Dalles 13
Xian 13
Cangzhou 12
Mumbai 12
Nuremberg 12
Delhi 11
Haiphong 11
Melbourne 11
Fremont 10
Kansas City 10
Nanning 10
New Delhi 10
Philadelphia 10
Qingdao 10
San Diego 10
Washington 10
Boston 9
Bucharest 9
Lima 9
Totale 6.515
Salva come PNG Salva come JPEG
Nome #
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out 2.574
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer 882
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 868
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis 630
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer 607
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study 480
Clinical implications for pro-GRP in small cell lung cancer. A single center experience 435
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 360
Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center 317
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial 295
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 285
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences 253
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapies 236
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer 233
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 226
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer 213
THE EUDRACT 2017-004494-13 TRIAL ON THYMIC EPITHELIAL TUMORS: THE PARADIGM OF A COMPREHENSIVE STUDY FOR A RARE DISEASE 210
Metformin plus /- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma : The FAME trial 210
Patient preferences for lung cancer treatments : A study protocol for a preference survey using discrete choice experiment and swing weighting 207
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional study 206
Trastuzumab cardiac toxicity : A problem we put our heart into 200
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review 200
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : results from Neo-ALTTO 197
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy 195
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors : a case series and literature review 183
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 176
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients 175
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature 175
Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment 95
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial 90
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database 36
null 3
Totale 11.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.743
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 0 92
2021/20221.163 118 120 96 83 104 56 76 85 132 118 44 131
2022/20231.011 111 134 109 88 64 167 34 86 92 33 44 49
2023/20241.399 45 54 41 54 91 47 222 186 99 170 195 195
2024/20251.487 165 191 143 170 66 56 36 123 82 139 100 216
2025/20262.403 258 152 212 162 182 152 346 83 222 162 384 88
Totale 11.452